SOS1/KRAS (Schrondinger)

N/A

Report date: 2025/01/26 15:43:28
NME

Base Information

Drug NameSOS1/KRAS (Schrondinger)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitorsSon of sevenless homolog 1 inhibitors
TargetsSon of sevenless homolog 1GTPase KRas
Therapy Area/IndicationsAdrenal Gland Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSchrodinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrodinger Inc
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsAdrenal Gland Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A